ORBIMED ADVISORS LLC
CIK 1055951
Transactions on file
146
Open-market buys
42
Win rate (buys)
88%
42 scored
Avg % since filing (buys)
+133.7%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 2,000 | $16.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-10 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,700 | $174.9K | +4.6% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 16,000 | $131.8K | +7.3% | open → |
| 2026-11-11 | 2026-11-09 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 4,000 | $33.0K | +7.3% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 39,600 | $310.9K | +12.6% | open → |
| 2026-11-11 | 2026-11-06 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,816 | $77.1K | +12.6% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 125,200 | $915.2K | +20.9% | open → |
| 2026-11-05 | 2026-11-05 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 30,891 | $225.8K | +20.9% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 20,000 | $141.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 5,000 | $35.4K | +25.0% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 37,100 | $288.6K | +13.6% | open → |
| 2026-11-05 | 2026-11-04 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 9,267 | $72.1K | +13.6% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 98,600 | $777.0K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,400 | $192.3K | +12.2% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 97,800 | $766.8K | +12.8% | open → |
| 2026-11-05 | 2026-11-03 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 24,313 | $190.6K | +12.8% | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -9.3% | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 507,119 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 625,743 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 616,984 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 642,745 | $0.00 | — | open → |
| 2026-11-04 | 2026-11-02 | ASPE Aspen Neuroscience, Inc. | Director10% | C | 196,541 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 588,235 | $10.00M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 61,516 | $1.05M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 256,448 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 513,067 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 1,333,975 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 7,127,019 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | Buy | 300,249 | $5.10M | +5.0% | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 564,187 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 769,601 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 2,000,962 | $0.00 | — | open → |
| 2026-09-30 | 2026-09-28 | ADRX ADARx Pharmaceuticals, Inc. | Director10% | C | 10,690,530 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 1,000,000 | $15.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 758,279 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | Buy | 333,333 | $5.00M | -41.1% | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,703,314 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 1,087,934 | $0.00 | — | open → |
| 2026-09-23 | 2026-09-21 | ETRA Electra Therapeutics, Inc. | Director10% | C | 2,002,310 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | Buy | 625,000 | $10.00M | +34.4% | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,049,283 | $0.00 | — | open → |
| 2026-08-12 | 2026-08-10 | BLSM BlossomHill Therapeutics, Inc. | Director | C | 1,039,996 | $0.00 | — | open → |
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | Buy | 273,333 | $4.92M | +60.6% | open → |
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | Buy | 1,666,667 | $30.00M | +60.6% | open → |
| 2026-08-11 | 2026-08-07 | BRVE Braveheart Bio, Inc. | Director10% | C | 9,132,420 | $0.00 | — | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Buy | 1,000,000 | $15.00M | +111.3% | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | C | 348,825 | $0.00 | — | open → |
| 2026-07-09 | 2026-07-07 | SION Sionna Therapeutics, Inc. | Director | Sale | 85,918 | $3.85M | -90.7% | open → |
| 2026-07-02 | 2026-06-30 | SION Sionna Therapeutics, Inc. | Director | Sale | 115,844 | $5.27M | -90.9% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 46,776 | $2.10M | +8.4% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 787,024 | $35.72M | +7.5% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 1,477 | $66.5K | +8.4% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 24,846 | $1.13M | +7.5% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 272,322 | $12.26M | +8.4% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 9,086 | $409.1K | +8.4% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 625,000 | $5.00M | +10.3% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 1,250,000 | $10.00M | +10.3% | open → |
| 2026-05-30 | 2026-05-27 | SION Sionna Therapeutics, Inc. | Director | Sale | 101 | $4.5K | -90.7% | open → |
| 2026-05-11 | 2026-05-11 | SION Sionna Therapeutics, Inc. | Director | Sale | 184,639 | $8.53M | -91.0% | open → |
| 2026-05-11 | 2026-05-08 | SION Sionna Therapeutics, Inc. | Director | Sale | 59,767 | $2.66M | -90.7% | open → |
| 2026-05-11 | 2026-05-07 | SION Sionna Therapeutics, Inc. | Director | Sale | 48,546 | $2.17M | -90.7% | open → |
| 2026-04-28 | 2026-04-16 | TRAW Traws Pharma, Inc. | 10% | Buy | 597,729 | $998.2K | -64.1% | open → |
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,126,126 | $5.00M | +10.6% | open → |
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,689,189 | $7.50M | +10.6% | open → |
| 2026-04-21 | 2026-04-18 | SION Sionna Therapeutics, Inc. | Director | Sale | 2,948 | $131.2K | -90.7% | open → |
| 2026-04-21 | 2026-04-17 | SION Sionna Therapeutics, Inc. | Director | Sale | 52,397 | $2.34M | -90.7% | open → |
| 2026-04-16 | 2026-04-16 | SION Sionna Therapeutics, Inc. | Director | Sale | 226,906 | $10.29M | -90.8% | open → |
| 2026-04-16 | 2026-04-15 | SION Sionna Therapeutics, Inc. | Director | Sale | 235,863 | $10.53M | -90.7% | open → |
| 2026-04-16 | 2026-04-14 | SION Sionna Therapeutics, Inc. | Director | Sale | 47,814 | $2.13M | -90.7% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 40,416 | $263.5K | +47.1% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 32,523 | $204.6K | +52.5% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 2,400 | $15.3K | +50.3% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 29,319 | $191.5K | +46.9% | open → |
| 2025-01-08 | 2025-01-08 | PASG Passage BIO, Inc. | 10% | Sale | 75,007 | $51.0K | +579.4% | open → |
| 2025-01-08 | 2025-01-07 | PASG Passage BIO, Inc. | 10% | Sale | 52,536 | $37.3K | +550.7% | open → |
| 2025-01-08 | 2025-01-06 | PASG Passage BIO, Inc. | 10% | Sale | 19,481 | $15.0K | +500.0% | open → |
| 2025-01-14 | 2025-01-14 | PASG Passage BIO, Inc. | 10% | Sale | 79,024 | $47.4K | +670.0% | open → |
| 2025-01-14 | 2025-01-10 | PASG Passage BIO, Inc. | 10% | Sale | 126,209 | $83.3K | +600.0% | open → |
| 2025-01-14 | 2025-01-13 | PASG Passage BIO, Inc. | 10% | Sale | 17,986 | $11.5K | +621.9% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director | Buy | 550,000 | $9.90M | -76.9% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director | C | 3,154,959 | — | — | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +453.4% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +402.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +450.6% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +402.9% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 68,766 | $3.73M | +47.4% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 10,733 | $584.3K | +47.0% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 106,384 | $5.78M | +47.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 26,596 | $1.44M | +47.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 136 | $7.5K | +45.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 211 | $11.6K | +45.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 53 | $2.9K | +45.4% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 9,222 | $498.1K | +48.1% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 14,267 | $770.6K | +48.1% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 3,567 | $192.7K | +48.1% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 603 | $33.2K | +45.3% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 933 | $51.4K | +45.3% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 233 | $12.8K | +45.3% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 42,930 | $2.34M | +47.0% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 27,750 | $1.51M | +47.0% | open → |
